drugset
drugset / Trial / NCT02268149

Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects

NCT02268149 ↗

Phase 1 Completed 20 enrolled Boehringer Ingelheim
RandomizedCrossoverDouble-blindTreatment

Summary

Study to evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokinetics of a single dose of prednisone

Timeline

Start
2000-04
Primary completion
2000-07
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject AMELUBANT Small molecule — —
Subject Prednisone Other / unclassified — —

Indications

No indication recorded.